Strategic Diagnostics Granted Continued Listing On Nasdaq National Market

NEWARK, Del.--(BUSINESS WIRE)--Jan. 25, 2006--Strategic Diagnostics Inc. (Nasdaq:SDIX) - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today announced that the Nasdaq Listing Qualifications Panel has granted the Company's request for continued listing on the Nasdaq National Market, subject to the requirement that the Company file its Quarterly Report on Form 10-Q for the period ended September 30, 2005 on or before March 20, 2006.